Lightspeed Microscopy reimagines pathology by providing a full-stack solution to nondestructively image large tissues in 3D at sub-cellular resolution. Its novel chemistry, patented high-throughput light-sheet microscope, and cloud-based AI analysis software adds a new dimension to pathology.
Date |
Amount |
Type |
Investors |
Valuation |
---|---|---|---|---|
06/15/21 | $4,000,000 | Series A |
Dynamk Capital![]() | undisclosed |